Clinical Trial Update: Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of exemestane in patients with complex atypical hyperplasia of the endometrium, endometrial intraepithelial neoplasia, or low-grade endom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Atypical Hyperplasia of the Endometrium
• Endometrial Cancer
• Endometrial Intraepithelial Neoplasia
• Endometrioid Endometrial Adenocarcinoma Figo

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED | Results posted: 2025-06-03